RecruitingNCT06080308

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

Research on the Molecular Mechanisms of Liver Ischemia-reperfusion Injury and Clinical Data Analysis: an Observational Study

Sponsor

Qin Zhang

Enrollment

270 participants

Start Date

Oct 10, 2023

Study Type

OBSERVATIONAL

Conditions

Searching for new targets for the diagnosis and treatment of liver ischemia-reperfusion injury.

Min Age: 18 YearsMax Age: 70 Years

Willingness to participate in the study and has signed an informed consent form. 2) Age ≥ 18 years and ≤ 70 years. 3) ASA classification ≤ III. 4) Criteria for liver ischemia-reperfusion injury patients: patients undergoing elective liver resection surgery with hepatic pedicle occlusion and reperfusion during the procedure.

\) Patients with adverse events during surgery. 2) Patients in the end stage of disease with liver failure. 3) Liver tumor metastasis with concomitant severe heart failure or chronic renal insufficiency, etc. 4) Deemed unsuitable for participation in the study based on the judgment of the researchers.
\-

Interested in this trial?

Get notified about updates and connect with the research team.